Charles M. Baum, M.D., Ph.D.

Charles M. Baum, M.D., Ph.D.

DirectoratPMV Pharmaceuticals· In proxies 2023–2025

Charles M. Baum, M.D., Ph.D. sits on 3 public boards.

Boards1

  • PMV PharmaceuticalsDirector · 4 yr on the boardIndependentCompensation, Nominating and Corporate Governance—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. PMV PharmaceuticalsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -83%
  2. Acrivon Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  3. Poseida Therapeutics, Inc.Public company · 3 yr
    • Director2022 – 2025 · 3 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?